1. Home
  2. RLMD vs SOHO Comparison

RLMD vs SOHO Comparison

Compare RLMD & SOHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • SOHO
  • Stock Information
  • Founded
  • RLMD 2004
  • SOHO 2004
  • Country
  • RLMD United States
  • SOHO United States
  • Employees
  • RLMD N/A
  • SOHO N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • SOHO Real Estate Investment Trusts
  • Sector
  • RLMD Health Care
  • SOHO Real Estate
  • Exchange
  • RLMD Nasdaq
  • SOHO Nasdaq
  • Market Cap
  • RLMD 20.3M
  • SOHO 18.0M
  • IPO Year
  • RLMD N/A
  • SOHO 2004
  • Fundamental
  • Price
  • RLMD $0.63
  • SOHO $0.76
  • Analyst Decision
  • RLMD Buy
  • SOHO Hold
  • Analyst Count
  • RLMD 3
  • SOHO 1
  • Target Price
  • RLMD $5.00
  • SOHO $1.50
  • AVG Volume (30 Days)
  • RLMD 142.9K
  • SOHO 49.4K
  • Earning Date
  • RLMD 08-07-2025
  • SOHO 08-12-2025
  • Dividend Yield
  • RLMD N/A
  • SOHO N/A
  • EPS Growth
  • RLMD N/A
  • SOHO N/A
  • EPS
  • RLMD N/A
  • SOHO N/A
  • Revenue
  • RLMD N/A
  • SOHO $180,257,976.00
  • Revenue This Year
  • RLMD N/A
  • SOHO $13.93
  • Revenue Next Year
  • RLMD N/A
  • SOHO N/A
  • P/E Ratio
  • RLMD N/A
  • SOHO N/A
  • Revenue Growth
  • RLMD N/A
  • SOHO 1.07
  • 52 Week Low
  • RLMD $0.24
  • SOHO $0.59
  • 52 Week High
  • RLMD $3.98
  • SOHO $1.54
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 51.70
  • SOHO 40.60
  • Support Level
  • RLMD $0.59
  • SOHO $0.80
  • Resistance Level
  • RLMD $0.64
  • SOHO $0.79
  • Average True Range (ATR)
  • RLMD 0.05
  • SOHO 0.05
  • MACD
  • RLMD 0.00
  • SOHO -0.01
  • Stochastic Oscillator
  • RLMD 55.00
  • SOHO 31.18

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About SOHO Sotherly Hotels Inc.

Sotherly Hotels Inc is engaged in Hotel operations. The company is a self-managed and self-administered lodging real estate investment trust that was formed to own, acquire, renovate, and reposition full-service, upscale, and upper-upscale hotel properties located in primary markets in the mid-Atlantic and southern United States. It generates revenue through the rooms, food, beverage, and other services. Geographically, the group has its presence in the regions of Florida, Georgia, Indiana, Maryland, North Carolina, Pennsylvania, Texas, and Virginia.

Share on Social Networks: